RHOA in Gastric Cancer: Functional Roles and Therapeutic Potential
The well-known signal mediator and small GTPase family member, RHOA, has now been associated with the progression of specific malignancies. In this review, we appraise the biomedical literature regarding the role of this enzyme in gastric cancer (GC) signaling, suggesting potential clinical signific...
Main Authors: | Seungyoon Nam, Jung Ho Kim, Dae Ho Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2019.00438/full |
Similar Items
-
RHOA protein expression correlates with clinical features in gastric cancer: a systematic review and meta-analysis
by: Seungyoon Nam, et al.
Published: (2022-07-01) -
Second-Generation JK-206 Targets the Oncogenic Signal Mediator RHOA in Gastric Cancer
by: Myeonghun Beak, et al.
Published: (2022-03-01) -
Genome-Scale Metabolic Model Analysis of Metabolic Differences between Lauren Diffuse and Intestinal Subtypes in Gastric Cancer
by: Seungyoon Nam, et al.
Published: (2022-05-01) -
WNT5A Correlates with Clinicopathological Characteristics in Gastric Cancer: a Meta-Analysis
by: Seungyoon Nam, et al.
Published: (2017-01-01) -
Performance Comparisons of AlexNet and GoogLeNet in Cell Growth Inhibition IC50 Prediction
by: Yeeun Lee, et al.
Published: (2021-07-01)